300 related articles for article (PubMed ID: 19009658)
1. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia.
Zhu FS; Liu S; Chen XM; Huang ZG; Zhang DW
World J Gastroenterol; 2008 Nov; 14(41):6395-400. PubMed ID: 19009658
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.
Boyraz M; Pirgon Ö; Dündar B; Çekmez F; Hatipoğlu N
J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):121-7. PubMed ID: 26316434
[TBL] [Abstract][Full Text] [Related]
3. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.
Capanni M; Calella F; Biagini MR; Genise S; Raimondi L; Bedogni G; Svegliati-Baroni G; Sofi F; Milani S; Abbate R; Surrenti C; Casini A
Aliment Pharmacol Ther; 2006 Apr; 23(8):1143-51. PubMed ID: 16611275
[TBL] [Abstract][Full Text] [Related]
4. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
Askari F; Rashidkhani B; Hekmatdoost A
Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
[TBL] [Abstract][Full Text] [Related]
5. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
Janczyk W; Lebensztejn D; Wierzbicka-Rucińska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and risk factors of patients with fatty liver in Guangzhou area.
Chen QK; Chen HY; Huang KH; Zhong YQ; Han JA; Zhu ZH; Zhou XD
World J Gastroenterol; 2004 Mar; 10(6):899-902. PubMed ID: 15040041
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia.
Hatzitolios A; Savopoulos C; Lazaraki G; Sidiropoulos I; Haritanti P; Lefkopoulos A; Karagiannopoulou G; Tzioufa V; Dimitrios K
Indian J Gastroenterol; 2004; 23(4):131-4. PubMed ID: 15333967
[TBL] [Abstract][Full Text] [Related]
12. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
13. The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin.
Gonciarz M; Gonciarz Z; Bielanski W; Mularczyk A; Konturek PC; Brzozowski T; Konturek SJ
J Physiol Pharmacol; 2010 Dec; 61(6):705-10. PubMed ID: 21224501
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study.
Kim SW; Ha KC; Choi EK; Jung SY; Kim MG; Kwon DY; Yang HJ; Kim MJ; Kang HJ; Back HI; Kim SY; Park SH; Baek HY; Kim YJ; Lee JY; Chae SW
BMC Complement Altern Med; 2013 Mar; 13():58. PubMed ID: 23497020
[TBL] [Abstract][Full Text] [Related]
15. Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.
Cui WX; Yang J; Chen XQ; Mao Q; Wei XL; Wen XD; Wang Q
Am J Chin Med; 2013; 41(3):487-502. PubMed ID: 23711137
[TBL] [Abstract][Full Text] [Related]
16. Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial.
Magosso E; Ansari MA; Gopalan Y; Shuaib IL; Wong JW; Khan NA; Abu Bakar MR; Ng BH; Yuen KH
Nutr J; 2013 Dec; 12(1):166. PubMed ID: 24373555
[TBL] [Abstract][Full Text] [Related]
17. Evaluating Efficacy and Safety of Combination Medication of Atorvastatin and a Herbal Formula Containing Salvia miltiorrhiza and Pueraria lobata on Hyperlipidemia.
Cheung DW; Koon CM; Wong PH; Yau KC; Wat E; Hung AS; Wang YP; Lau KM; Ko CH; Chan JY; Waye MM; Fung KP
Phytother Res; 2017 Oct; 31(10):1579-1589. PubMed ID: 28840970
[TBL] [Abstract][Full Text] [Related]
18. Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.
Oh HJ; Kim TH; Sohn YW; Kim YS; Oh YR; Cho EY; Shim SY; Shin SR; Han AL; Yoon SJ; Kim HC
Korean J Hepatol; 2011 Mar; 17(1):27-36. PubMed ID: 21494075
[TBL] [Abstract][Full Text] [Related]
19. Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study.
Chen LW; Huang MS; Shyu YC; Chien RN
Kaohsiung J Med Sci; 2021 Sep; 37(9):819-827. PubMed ID: 34002481
[TBL] [Abstract][Full Text] [Related]
20. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease.
Spadaro L; Magliocco O; Spampinato D; Piro S; Oliveri C; Alagona C; Papa G; Rabuazzo AM; Purrello F
Dig Liver Dis; 2008 Mar; 40(3):194-9. PubMed ID: 18054848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
